Phase Ib Study of Enzalutamide with or Without Sorafenib in Patients with Advanced Hepatocellular Carcinoma.
Saved in:
| Title: | Phase Ib Study of Enzalutamide with or Without Sorafenib in Patients with Advanced Hepatocellular Carcinoma. |
|---|---|
| Authors: | Harding JJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA., Kelley RK; Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA., Tan B; Department of Medicine, Washington University, St. Louis, Missouri, USA., Capanu M; Department of Epidemiology-Biostatistics, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA., Do GK; Department of Radiology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA., Shia J; Department of Pathology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA., Chou JF; Department of Epidemiology-Biostatistics, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA., Ferrer CS; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA., Boussayoud C; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA., Muenkel K; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA., Yarmohammadi H; Department of Radiology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA., El Dika I; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA., Khalil DN; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA., Ruiz C; University of Southern California USC Michelson Center, Los Angeles, California, USA., Rodriguez-Lee M; University of Southern California USC Michelson Center, Los Angeles, California, USA., Kuhn P; University of Southern California USC Michelson Center, Los Angeles, California, USA., Wilton J; Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA., Iyer R; Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York, USA., Abou-Alfa GK; Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA. |
| Source: | The oncologist [Oncologist] 2020 Dec; Vol. 25 (12), pp. e1825-e1836. Date of Electronic Publication: 2020 Jul 02. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1549-490X |
|---|---|
| DOI: | 10.1634/theoncologist.2020-0521 |
